Literature DB >> 31712917

Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution.

Alex Yu1, Mark J Koenigsknecht1, Bart Hens1,2, Jason R Baker3, Bo Wen1, Trachette L Jackson4, Manjunath P Pai5, William Hasler3, Gordon L Amidon1, Duxin Sun6,7.   

Abstract

Multiple approaches such as mathematical deconvolution and mechanistic oral absorption models have been used to predict in vivo drug dissolution in the gastrointestinal (GI) tract. However, these approaches are often validated by plasma pharmacokinetic profiles, but not by in vivo drug dissolution due to the limited data available regarding the local GI environment. It is also challenging to predict and validate in vivo dissolution in different regions of the GI tract (stomach, duodenum, jejunum, and ileum). In this study, the dynamic fluid compartment absorption and transport (DFCAT) model was used to predict the in vivo dissolution profiles of ibuprofen, which was administered as an 800-mg immediate-release tablet to healthy subjects, in different regions of the GI tract. The prediction was validated with concentration time-courses of ibuprofen (BCS class 2a) in different regions of the GI tract that we have obtained over the past few years. The computational model predicted that the dissolution of ibuprofen was minimal in the stomach (2%), slightly more in the duodenum (6.3%), and primarily dissolved in the jejunum (63%) and the ileum (25%). The detailed model prediction of drug dissolution in different regions of GI can provide a quantitative reference of in vivo dissolution that may provide valuable insight in developing in vitro tests for drug product optimization and quality.

Entities:  

Keywords:  absorption; deconvolution; dissolution; mechanistic; modeling

Mesh:

Substances:

Year:  2019        PMID: 31712917      PMCID: PMC8848304          DOI: 10.1208/s12248-019-0385-z

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  23 in total

1.  Equilibrium drug solubility measurements in 96-well plates reveal similar drug solubilities in phosphate buffer pH 6.8 and human intestinal fluid.

Authors:  Tiina Heikkilä; Milja Karjalainen; Krista Ojala; Kirsi Partola; Frank Lammert; Patrick Augustijns; Arto Urtti; Marjo Yliperttula; Leena Peltonen; Jouni Hirvonen
Journal:  Int J Pharm       Date:  2010-12-10       Impact factor: 5.875

2.  Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data.

Authors:  Viera Lukacova; Walter S Woltosz; Michael B Bolger
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

3.  Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs.

Authors:  Bart Hens; Yasuhiro Tsume; Marival Bermejo; Paulo Paixao; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Joseph Dickens; Kerby Shedden; Bo Wen; Jeffrey Wysocki; Raimar Loebenberg; Allen Lee; Ann Frances; Greg Amidon; Alex Yu; Gail Benninghoff; Niloufar Salehi; Arjang Talattof; Duxin Sun; Gordon L Amidon
Journal:  Mol Pharm       Date:  2017-08-04       Impact factor: 4.939

4.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

5.  Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract.

Authors:  Alex Yu; Jason R Baker; Ann F Fioritto; Ying Wang; Ruijuan Luo; Siwei Li; Bo Wen; Michael Bly; Yasuhiro Tsume; Mark J Koenigsknecht; Xinyuan Zhang; Robert Lionberger; Gordon L Amidon; William L Hasler; Duxin Sun
Journal:  Mol Pharm       Date:  2016-12-23       Impact factor: 4.939

6.  Effect of gastric and transpyloric tubes on gastric emptying and duodenogastric reflux.

Authors:  S A Müller-Lissner; C J Fimmel; N Will; W Müller-Duysing; F Heinzel; A L Blum
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

Review 7.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

8.  Pharmacokinetics of ibuprofen.

Authors:  K S Albert; C M Gernaat
Journal:  Am J Med       Date:  1984-07-13       Impact factor: 4.965

9.  In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.

Authors:  Mark J Koenigsknecht; Jason R Baker; Bo Wen; Ann Frances; Huixia Zhang; Alex Yu; Ting Zhao; Yasuhiro Tsume; Manjunath P Pai; Barry E Bleske; Xinyuan Zhang; Robert Lionberger; Allen Lee; Gordon L Amidon; William L Hasler; Duxin Sun
Journal:  Mol Pharm       Date:  2017-10-05       Impact factor: 4.939

10.  Deconvolution and IVIVC: Exploring the Role of Rate-Limiting Conditions.

Authors:  Alison Margolskee; Adam S Darwich; Aleksandra Galetin; Amin Rostami-Hodjegan; Leon Aarons
Journal:  AAPS J       Date:  2015-12-14       Impact factor: 4.009

View more
  2 in total

1.  Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.

Authors:  Min Li; Xinwen Zhang; Di Wu; Om Anand; Hansong Chen; Kimberly Raines; Lawrence Yu
Journal:  AAPS J       Date:  2021-10-26       Impact factor: 4.009

Review 2.  Current State and Challenges of Physiologically Based Biopharmaceutics Modeling (PBBM) in Oral Drug Product Development.

Authors:  Di Wu; Min Li
Journal:  Pharm Res       Date:  2022-09-08       Impact factor: 4.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.